Global Neuromonitoring Devices Size, Trends & Growth Opportunity, By Product and By Region Forecast till 2027.
Report ID : QR1001496 | Industries : Healthcare | Published On :June 2022 | Page Count : 240Global Neuromonitoring Devices Market
The global neuromonitoring devices market is predicted to generate $8,276.0 million in the 2022-2027 forecast period, growing from $5593.1 million in 2021, at a healthy CAGR of 7.24%.
The Global "Neuromonitoring Devices Market" report delivers a comprehensive evaluation of the market. It does give comprehensive analysis via qualitative insights, historic data, and supportable projections about market size. The forecasts involved in the report have been derived using confirmed research methodologies and assumptions. The report contains total in-depth analysis of Neuromonitoring Devices growth, segmentation, regional and country breakdowns. This report can deliver a complete study of the drivers, expansion policies, SWOT analysis and Covid-19 impact and growing recovery. This research will give a rich and accurate idea about the overall market to the readers to take valuable decisions.
Know more about this report: request for sample pages
Segment Overview
The subsequent section gives a summary of the report to give an indication of the type and content of the study, in addition to providing an overview of the Wafer Level Packing.
Market Dynamics delivers an in-depth analysis of the key market drivers, restraints, challenges, trends, and opportunities.
Application Segments shows market development and different types of several End-User.
Application Segments include evaluation of the business potential of important applications and identified future opportunities.
Geographic segments are judiciously looked at to understand its present and future growth scenarios.
Moreover, the Neuromonitoring Devices also offers a comprehensive overview of market opportunities By Products, segment, product segment, sales channel, major countries, and import and export dynamics.
Key Players
Top Leading Companies of Global Neuromonitoring Devices Market are GE Healthcare, Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corporation, Natus Medical Incorporated, Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, LLC, Specialtycare, RIMED Ltd.
Market Taxonomy
By Product
- Intracranial Pressure Monitoring
- Cerebral Oximeter
- Near Infrared Spectroscopy
- Speckle Imaging
- Doppler Ultrasound
- EEG
- Fetal/Neonatal Neuro-Monitoring Devices
- Micro Ultrasound
- Others
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Global Neuromonitoring Devices Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Feedstock Types
3 Executive Summary
4 Global Neuromonitoring Devices Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Neuromonitoring Devices Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Neuromonitoring Devices Market Share Analysis, By Product
5.3 Global Neuromonitoring Devices Market Size and Forecast, By Product
5.3.1 Intracranial Pressure Monitoring
5.3.2 Cerebral Oximeter
5.3.3 Near Infrared Spectroscopy
5.3.4 Speckle Imaging
5.3.5 Doppler Ultrasound
5.3.6 EEG
5.3.7 Fetal/Neonatal Neuro-Monitoring Devices
5.3.8 Micro Ultrasound
5.3.9 Others
6 Global Neuromonitoring Devices Market, By Region
6.1 Global Neuromonitoring Devices Market Share Analysis, By Region
6.2 Global Neuromonitoring Devices Market Share Analysis, By Region
6.3 Global Neuromonitoring Devices Market Size and Forecast, By Region
7 North America Global Neuromonitoring Devices Market Analysis and Forecast (2022 – 2027)
7.1 Introduction
7.2 North America Global Neuromonitoring Devices Market Share Analysis, By Product
7.3 North America Global Neuromonitoring Devices Market Size and Forecast, By INDUSTRY VERTICAL
7.4 North America Global Neuromonitoring Devices Market Size and Forecast, By Country
7.4.1 U.S.
7.4.2 Canada
7.4.3 Mexico
8 Europe Global Neuromonitoring Devices Market Analysis and Forecast (2022 – 2027)
8.1 Introduction
8.2 Europe Global Neuromonitoring Devices Market Share Analysis, By Product
8.3 Europe Global Neuromonitoring Devices Market Size and Forecast, By INDUSTRY VERTICAL
8.4 Europe Global Neuromonitoring Devices Market Size and Forecast, By Country
8.4.1 Germany
8.4.2 France
8.4.3 UK
8.4.4. Rest of Europe
9 Asia Pacific Global Neuromonitoring Devices Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Asia Pacific Global Neuromonitoring Devices Market Share Analysis, By Product
9.3 Asia Pacific Global Neuromonitoring Devices Market Size and Forecast, By INDUSTRY VERTICAL
9.4 Asia Pacific Global Neuromonitoring Devices Market Size and Forecast, By Country
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4. Rest of Asia Pacific
10 Latin America Global Neuromonitoring Devices Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Latin America Global Neuromonitoring Devices Market Share Analysis, By Product
10.3 Latin America Global Neuromonitoring Devices Market Size and Forecast, By INDUSTRY VERTICAL
10.4 Latin America Global Neuromonitoring Devices Market Size and Forecast, By Country
10.4.1. Brazil
10.4.2. Rest of Latin America
11 Middle East Global Neuromonitoring Devices Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Middle East Global Neuromonitoring Devices Market Share Analysis, By Product
11.3 Middle East Global Neuromonitoring Devices Market Size and Forecast, By INDUSTRY VERTICAL
11.4 Middle East Global Neuromonitoring Devices Market Size and Forecast, By Country
11.4.1. Saudi Arabia
11.4.2. UAE
11.4.3. Egypt
11.4.4. Kuwait
11.4.5. South Africa
12 Competitive Analysis
12.1 Competition Dashboard
12.2 Market share Analysis of Top Vendors
12.3 Key Development Strategies
13 Company Profiles
13.1 GE Healthcare
13.1.1 Overview
13.1.2 Offerings
13.1.3 Key Financials
13.1.4 Business Segment & Geographic Overview
13.1.5 Key Market Developments
13.1.6 Key Strategies
13.2 Koninklijke Philips N.V.
13.2.1 Overview
13.2.2 Offerings
13.2.3 Key Financials
13.2.4 Business Segment & Geographic Overview
13.2.5 Key Market Developments
13.2.6 Key Strategies
13.3 Medtronic Plc
13.3.1 Overview
13.3.2 Offerings
13.3.3 Key Financials
13.3.4 Business Segment & Geographic Overview
13.3.5 Key Market Developments
13.3.6 Key Strategies
13.4 Nihon Kohden Corporation
13.4.1 Overview
13.4.2 Offerings
13.4.3 Key Financials
13.4.4 Business Segment & Geographic Overview
13.4.5 Key Market Developments
13.4.6 Key Strategies
13.5 Natus Medical Incorporated
13.5.1 Overview
13.5.2 Offerings
13.5.3 Key Financials
13.5.4 Business Segment & Geographic Overview
13.5.5 Key Market Developments
13.5.6 Key Strategies
13.6 Nuvasive, Inc.
13.6.1 Overview
13.6.2 Offerings
13.6.3 Key Financials
13.6.4 Business Segment & Geographic Overview
13.6.5 Key Market Developments
13.6.6 Key Strategies
13.7 Advanced Brain Monitoring, Inc.
13.7.1 Overview
13.7.2 Offerings
13.7.3 Key Financials
13.7.4 Business Segment & Geographic Overview
13.7.5 Key Market Developments
13.7.6 Key Strategies
13.8 Intranerve Neuroscience Holdings, LLC
13.8.1 Overview
13.8.2 Offerings
13.8.3 Key Financials
13.8.4 Business Segment & Geographic Overview
13.8.5 Key Market Developments
13.8.6 Key Strategies
13.9 Specialtycare
13.9.1 Overview
13.9.2 Offerings
13.9.3 Key Financials
13.9.4 Business Segment & Geographic Overview
13.9.5 Key Market Developments
13.9.6 Key Strategies
13.10 RIMED Ltd.
13.10.1 Overview
13.10.2 Offerings
13.10.3 Key Financials
13.10.4 Business Segment & Geographic Overview
13.10.5 Key Market Developments
13.10.6 Key Strategies